Skip to main content
Clinical Trials/CTRI/2024/08/072285
CTRI/2024/08/072285
Not yet recruiting
Phase 2

A randomized controlled clinical trial to study the effect of devdaru choorna in prameha with special reference to diabetes mellitus – type 2 - NA

Dr Samiksha Bhure0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Dr Samiksha Bhure
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Samiksha Bhure

Eligibility Criteria

Inclusion Criteria

  • Patient showing signs and symptoms of Prameha such as –1\.Prabhuta Mutrata (polyuria)
  • 2\. Avila Mutrata(unclear urine))
  • 3\. Ati\-sweda (sweating)
  • 4\. Daurbalya(weakness)
  • 5\. Pipasa(polydipsia)
  • 6\. Kshudavriddhi (Polyphagia)
  • 7\.Pipilika sancharanvat prachiti
  • 8\. Kara dahapada (Burning sensation)
  • 9\. Naktamutrata (Nocturnal urination)
  • and patient already diagnosed with DM type 2 such as –

Exclusion Criteria

  • 1\.IDDM, Acromegaly, Cushing’s syndrome and Pancreatic disorder.
  • 2\. Pregnant and lactating women.
  • 3\. Patient with gestational diabetes.
  • 4\. Patient suffering from Hepatic dysfunction, Renal dysfunction or Liver cirrhosis.
  • 5\. Patient in whom DM is caused as drug induced complication.
  • 6\. Those who are under Insulin therapy.
  • 7\. Patient with DKA, Lactic acidosis, Sepsis.
  • 8\. Patients with acute complications like hyperglycaemic coma, ketoacidosis and infections like gangrene.
  • 9\. Patients with K/C/O Nephropathy, Neuropathy and Retinopathy.
  • 10\. Patients with conditions like cardiovascular disease, acute MI, Immune compromised disease \[HIV].

Outcomes

Primary Outcomes

Not specified

Similar Trials